Founded in 1994, Cell Marque has 25 years of experience in the production of antibodies for clinical pathology. The Cell Marque antibody product line offers an abundant portfolio of primary antibodies suitable for diagnostic use in immunohistochemistry (IHC), on formalin-fixed, paraffin-embedded tissue samples. Their in vitro diagnostic (IVD) range includes novel antibodies, detection systems, and advanced ancillary reagents for clinical testing in the histopathology laboratory. With a medical team on staff, Cell Marque’s development strategy means maintaining relentless dedication to the latest clinical needs to further serve the market, and to supply you with the best care for your patients.
Cell Marque’s reputation as a provider of high quality, fit-for-purpose IHC antibodies and reagents was further enhanced following its acquisition by Sigma-Aldrich in 2014. Now part of MilliporeSigma, the US life science business of Merck KGaA based in Darmstadt, Germany; Cell Marque’s products and scientific expertise complement Sigma-Aldrich’s workflow solutions aimed at IVD customers.
To assist with product selection, primary antibodies are organised according to histopathology speciality. Within their extensive portfolio can be found monoclonal and polyclonal antibodies for use in anatomic pathology, breast & gynaecological pathology, cytopathology, dermatopathology, gastrointestinal (GI) pathology, genitourinary (GU) pathology, head and neck pathology, hematopathology, neuropathology, paediatric pathology, pulmonary pathology and soft tissue pathology. Additionally, Cell Marque’s IHC product portfolio also includes substrates and detection systems, control slides, blocking buffers and diluents.